Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is funded by PER®.

The Gut Microbiome and Immunotherapy

Release Date: June 29, 2021
Expiration Date: June 29, 2022

Activity Overview

This continuing medical education (CME) activity is designed to inform health care providers involved in the clinical care of patients with cancer of emerging data surrounding the modulation of the gut microbiome to improve efficacy and reduce adverse effects of immune checkpoint inhibitors. This in-depth program will cover recent updates regarding clinical trials investigating emerging strategies to modulate the gut microbiome, including key data and their potential clinical implications for the therapeutic landscape across tumor types.

Acknowledgment of Support

This activity is funded by PER^®.

Instructions for This Activity and Receiving Credit

Complete the activity (including pre- and post-activity assessments).
Answer the evaluation questions.
Request credit using the drop-down menu.

You may immediately download your certificate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Describe the associations between the gut microbiome and immunotherapy
Assess key data from ongoing clinical trials evaluating gut microbiome biomarkers for the use of immunotherapy
Outline potential strategies to modulate the gut microbiome to improve efficacy of immunotherapy

Faculty

Jennifer McQuade, MD, MS, MA, LAc
Assistant Professor
Department of Melanoma Medical Oncology
MD Anderson Cancer Center
Houston, Texas

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.